Title : Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.

Pub. Date : 1998 Feb

PMID : 9506248






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In single-dose studies comparing the two long-acting beta 2-agonists formoterol and salmeterol, significant bronchodilation is achieved more rapidly with formoterol than salmeterol. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens
2 In single-dose studies comparing the two long-acting beta 2-agonists formoterol and salmeterol, significant bronchodilation is achieved more rapidly with formoterol than salmeterol. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens
3 Formoterol is currently recommended for use as an alternative to increasing inhaled steroid dosage in patients whose symptoms are inadequately controlled despite therapy with low to moderate doses of inhaled steroids and intermittent short-acting beta 2-agonists, and results of recent studies support therapeutic guidelines. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens